Product
Vehicle Ophthalmic Solution
1 clinical trial
4 indications
Indication
Corneal Endothelial Cell LossIndication
Eye PainIndication
Ocular InflammationIndication
Cataract SurgeryClinical trial
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Phase 2 Study of the Efficacy and Safety of RTA 408 For the Prevention of Corneal Endothelial Cell Loss in Patients Undergoing Cataract SurgeryStatus: Completed, Estimated PCD: 2015-02-28